Verona Pharma PLC American Depositary Share (VRNA) closed the last trading session at $90.48, gaining 6.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $114 indicates a 26% upside potential.The average comprises 10 short-term price targets ranging from a low of $90.00 to a high of $160.00, with a standard deviation of $23.98. While the lowest estimate indicates a decline of 0.5% ...

Shares of International Seaways (INSW) have gained 6.1% over the past four weeks to close the last trading session at $38.5, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $58.4 indicates a potential upside of 51.7%.The mean estimate comprises five short-term price targets with a standard deviation of $9.94. While the lowest estimate of $48.00 indicates a 24.7% increase from th ...

Shares of Ardmore Shipping (ASC) have gained 6.4% over the past four weeks to close the last trading session at $10.08, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $13.17 indicates a potential upside of 30.7%.The average comprises three short-term price targets ranging from a low of $12.50 to a high of $14.00, with a standard deviation of $0.76. While the lowest estimate ind ...

HUTCHMED (HCM) closed the last trading session at $14.84, gaining 10.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $25.75 indicates a 73.5% upside potential.The average comprises four short-term price targets ranging from a low of $18.00 to a high of $39.00, with a standard deviation of $9.71. While the lowest estimate indicates an increase of 21.3% from the current price leve ...

Shares of Arvinas, Inc. (ARVN) have gained 13.9% over the past four weeks to close the last trading session at $7.39, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.03 indicates a potential upside of 89.9%.The mean estimate comprises 17 short-term price targets with a standard deviation of $4.54. While the lowest estimate of $8 indicates an 8.3% increase from the current pr ...

Shares of Apogee Therapeutics Inc. (APGE) have gained 9.9% over the past four weeks to close the last trading session at $40.98, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $93.88 indicates a potential upside of 129.1%.The average comprises eight short-term price targets ranging from a low of $78 to a high of $116, with a standard deviation of $11.05. While the lowest estima ...

Shares of Monte Rosa Therapeutics (GLUE) have gained 22.5% over the past four weeks to close the last trading session at $5.01, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $16.14 indicates a potential upside of 222.2%.The mean estimate comprises seven short-term price targets with a standard deviation of $3.98. While the lowest estimate of $10 indicates a 99.6% increase from ...

Shares of Phathom Pharmaceuticals, Inc. (PHAT) have gained 184.1% over the past four weeks to close the last trading session at $8.92, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $18.50 indicates a potential upside of 107.4%.The mean estimate comprises eight short-term price targets with a standard deviation of $8.09. While the lowest estimate of $5 indicates a 44% decline f ...

LifeStance Health Group (LFST) closed the last trading session at $5.95, gaining 8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $8.63 indicates a 45% upside potential.The average comprises eight short-term price targets ranging from a low of $7 to a high of $10, with a standard deviation of $1.03. While the lowest estimate indicates an increase of 17.7% from the current price l ...

Shares of Synaptics (SYNA) have gained 7.3% over the past four weeks to close the last trading session at $62.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $87.86 indicates a potential upside of 40.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $11.85. While the lowest estimate of $80 indicates a 28% increase from the current pri ...